
MD. Ole M. Bech Joins Anyo Labs as an Advisor
NewsPublished 31 mars 2025
Novo Nordisk VP, MD. Ole M Bech, joins Anyo Labs advisory board.
MD. Ole M Bech, a VP at Novo Nordisk with a long track record of building international relationships and driving clinical-phase business, joined Anyo Labs to bring a big pharma perspective to transforming drug discovery. With a deep understanding of market forces, demands and clinical needs worldwide Bech will contribute to Anyo´s future development into various therapeutic areas.
We have already engaged in highly productive discussions and collaborated on some key aspects of our business, where Bech's perspectives have been extremely valuable. - Albin Boman CEO